Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Sil Choi

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|September 25, 2008
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancerJae Jin Lee, Si-Young Kim, Hyun-Cheol Chung, et al.
Cancer Research and Treatment|April 7, 2010
Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patientsJin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2014
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancerKeun-Wook Lee, Yu Jung Kim, Kyung-Hun Lee, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trialKeun-Wook Lee, Dae Young Zang, Min-Hee Ryu, et al.
Journal of Neuro-Oncology|March 15, 2003
Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiformeIn Sil Choi, Se Hoon Lee, Tae-You Kim, et al.
Journal of Breast Cancer|December 30, 2017
Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective AnalysisJin Hyun Park, Seock-Ah Im, Ja Min Byun, et al.
Journal of Korean Medical Science|October 15, 2005
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancerJee Hyun Kim, Do-Youn Oh, Yu Jung Kim, et al.
Cancer Research and Treatment|October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized TrialsJaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 26, 2012
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survivalEun Joo Kang, Seock-Ah Im, Do-Youn Oh, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|September 25, 2008
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancerJae Jin Lee, Si-Young Kim, Hyun-Cheol Chung, et al.
Cancer Research and Treatment|April 7, 2010
Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patientsJin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2014
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancerKeun-Wook Lee, Yu Jung Kim, Kyung-Hun Lee, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trialKeun-Wook Lee, Dae Young Zang, Min-Hee Ryu, et al.
Journal of Neuro-Oncology|March 15, 2003
Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiformeIn Sil Choi, Se Hoon Lee, Tae-You Kim, et al.
Journal of Breast Cancer|December 30, 2017
Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective AnalysisJin Hyun Park, Seock-Ah Im, Ja Min Byun, et al.
Journal of Korean Medical Science|October 15, 2005
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancerJee Hyun Kim, Do-Youn Oh, Yu Jung Kim, et al.
Cancer Research and Treatment|October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized TrialsJaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 26, 2012
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survivalEun Joo Kang, Seock-Ah Im, Do-Youn Oh, et al.
Pageof 7